Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Blank

Showing results (121-130 of 317) with videos related to

Pageof 32
Sort By:
Cancers|March 11, 2023
Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990-2019)Florine L Boer, Vincent K Y Ho, Marieke W J Louwman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2022
Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanomaElisa A Rozeman, Judith M Versluis, Ruben Moritz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access ProgramCornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Melanoma Research|December 22, 2022
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistanceDisha Rao, Ruben Lacroix, Alex Rooker, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2023
Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgeryLisanne P Zijlker, Stijn J C van der Burg, Christian U Blank, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 12, 2008
Improving outcomes with long-term "destination" therapy using left ventricular assist devicesJames W Long, Aaron H Healy, Brad Y Rasmusson, et al.
Scientific Reports|May 23, 2026
Explainable machine learning identifies features and thresholds predictive of immunotherapy responseKhoa A Tran, Venkateswar Addala, Lambros T Koufariotis, et al.
Cancer Research Communications|April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and RecurrenceEsmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Journal of the National Cancer Institute|July 10, 2026
Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohortAxel Nelson, Ellen Krabbe, Karl Björkström, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Pageof 32

Showing results (121-130 of 317) with videos related to

Sort By:
Pageof 32
Cancers|March 11, 2023
Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990-2019)Florine L Boer, Vincent K Y Ho, Marieke W J Louwman, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2022
Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanomaElisa A Rozeman, Judith M Versluis, Ruben Moritz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access ProgramCornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Melanoma Research|December 22, 2022
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistanceDisha Rao, Ruben Lacroix, Alex Rooker, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2023
Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgeryLisanne P Zijlker, Stijn J C van der Burg, Christian U Blank, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 12, 2008
Improving outcomes with long-term "destination" therapy using left ventricular assist devicesJames W Long, Aaron H Healy, Brad Y Rasmusson, et al.
Scientific Reports|May 23, 2026
Explainable machine learning identifies features and thresholds predictive of immunotherapy responseKhoa A Tran, Venkateswar Addala, Lambros T Koufariotis, et al.
Cancer Research Communications|April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and RecurrenceEsmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Journal of the National Cancer Institute|July 10, 2026
Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohortAxel Nelson, Ellen Krabbe, Karl Björkström, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Pageof 32